Sort
30,917 grants matching “tumor microenvironment”
IDO-mediated immune regulation in established tumors
$240,103David H Munn · Augusta University · R01 · FY2014 · CA
A Phase I Safety and Immunogenicity Study of a HPV16-Specific Therapeutic Protei
$240,095T.-C. Wu · Johns Hopkins University · P50 · FY2014 · CA
Project 2: Overcoming GBM RT-resistance
$240,081Daniel R Wahl · University Of Michigan At Ann Arbor · P50 · FY2025 · CA
The role of bone marrow macrophages in skeletal metastasis
$240,052Laurie K. McCauley · University Of Michigan At Ann Arbor · P01 · FY2016 · CA
Integrated Microchips for Informative Diagnosis of Cancer-immune Interactions
$240,000Rong Fan · Yale University · R00 · FY2010 · CA
Metabolic adaptation in residual triple negative breast cancer following chemotherapy
$240,000Gloria Vittone Echeverria · Baylor College Of Medicine · R37 · FY2025 · CA
Molecularly targeted photothermal ablation to enhance the therapeutic efficacy of immunomodulatory therapies in hepatocellular carcinoma
$240,000Rahul Anil Sheth · University Of Tx Md Anderson Can Ctr · R21 · FY2019 · EB
Analyzing Cell-Cell Fusion in Glioblastoma Growth and Progression
$240,000Joseph H McCarty · University Of Tx Md Anderson Can Ctr · R21 · FY2019 · NS
Mechanisms by which Polarity Proteins Regulate Initiation and Progression of Brea
$240,000Senthil K Muthuswamy · Cold Spring Harbor Laboratory · R56 · FY2008 · CA
Measuring Tumor Acidosis with PET/MRI Contrast Agents
$240,000Mark David Pagel · University Of Tx Md Anderson Can Ctr · R21 · FY2019 · EB
IDO inhibitors for combinatorial cancer therapy
$239,997George C Prendergast · Lankenau Institute For Medical Research · R01 · FY2015 · CA
Real-Time Optical Diagnostics of Tissue for PDT Dosimetry and Treatment Character
$239,971Arjun G Yodh · University Of Pennsylvania · P01 · FY2011 · CA
SYSTEMIC T CELL IMMUNOTHERAPY OF MALIGNANT GLIOMAS
$239,904Cleveland Clinic Foundation · R01 · FY2000 · CA
Multiscale Computational Oncology Research Core
$239,894Elana Fertig · University Of Tx Md Anderson Can Ctr · U54 · FY2023 · CA
HLA-F in maternal-fetal immune crosstalks
$239,850Marlene Bouvier · University Of Illinois At Chicago · R21 · FY2023 · AI
The role of marginal zone macrophages and immuno-metabolism in tumor-driven MDSC development
$239,637Tracy L McGaha · University Health Network · R01 · FY2020 · CA
Tumor Growth and Microenvironment Influence T Cell Tolerance to Tumor Antigens
$239,544Arthur Hurwitz · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
A Mouse model of TGFbeta1 and ras oncogene interactions
$239,544Adam B Glick · Pennsylvania State University, The · R01 · FY2007 · CA
A Mouse model of TGFbeta1 and ras oncogene interactions
$239,514Adam B Glick · Pennsylvania State University, The · R01 · FY2009 · CA
Tissue-based predictive biomarkers for Cabozantinib therapy in metastatic renal cell carcinoma
$239,504Sabina Signoretti · Brigham And Women'S Hospital · R21 · FY2021 · CA
MAP KINASE REGULATION OF MICROGLIAL ACTIVATION
$239,500Medical University Of South Carolina · R01 · FY2001 · NS
The role of Twist in inducing breast cancer initiating cells and metastasis
$239,352Venu Raman · Johns Hopkins University · R01 · FY2012 · CA
Impact of radiation-induced senescence on the glioblastoma microenvironment
$239,262Terry Burns · Mayo Clinic Rochester · R21 · FY2019 · NS
Prostate Cancer Induces CCL2 Expression and Transforms the Bone Microenvi
$239,253Kenneth J. Pienta · University Of Michigan At Ann Arbor · P01 · FY2010 · CA
Test if antitumor T cells use a putative super-enhancer in the Il1rl2-Il1rl1 intergenic region to form "innate-like" responses to cytokines
$239,250Adam J Adler · University Of Connecticut Sch Of Med/Dnt · R21 · FY2019 · AI